Calumet, Inc. (CLMT)
NASDAQ: CLMT · Real-Time Price · USD
21.32
+0.51 (2.45%)
Nov 21, 2024, 12:12 PM EST - Market open

Company Description

Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally.

It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.

The Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products.

The Montana/Renewables segment focuses on processing renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha.

It also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt.

The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands.

The company serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.

Calumet, Inc.
Calumet logo
Country United States
Founded 1916
IPO Date Jan 26, 2006
Industry Oil & Gas Exploration & Production
Sector Energy
Employees 1,580
CEO Louis Borgmann

Contact Details

Address:
1060 N Capitol Ave, Suite 6-401
Indianapolis, Indiana 46204-1044
United States
Phone 317-328-5660
Website calumet.com

Stock Details

Ticker Symbol CLMT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001340122
CUSIP Number 131476103
ISIN Number US1314761032
Employer ID 35-1811116
SIC Code 2911

Key Executives

Name Position
Louis Todd Borgmann President, Chief Executive Officer and Director of Calumet GP, LLC
Vincent Donargo Chief Accounting Officer and Principal Accounting Officer
Gregory J. Morical Senior Vice President, General Counsel and Secretary of Calumet GP, LLC
Scott Obermeier Executive Vice President of Specialties of Calumet GP, LLC
David A. Lunin Executive Vice President and Chief Financial Officer of Calumet GP, LLC
John Kompa Director of Investor Relations
Chris Hodges Alpha IR

Latest SEC Filings

Date Type Title
Aug 1, 2024 15-12G Securities registration termination
Aug 1, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 1, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 1, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 1, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 1, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Jul 10, 2024 8-K Current Report
Jul 5, 2024 8-K Current Report
Jun 7, 2024 DEFM14A Filing
May 10, 2024 10-Q Quarterly Report